Sonara key facts
as of Oct 2026- Developer of a telehealth software designed to meet the specific needs of opioid addiction clinics and their patients.
- Sonara is valued at approximately $13.0M as of Oct 2026 (last reported valuation).
- It has raised $10.2M; the latest was Later Stage VC ($4.4M) in Aug 2025.
- Notable investors include VentureWell, Mark Cuban, First Trust Capital Partners, Sorenson Impact Foundation, Oakwood Circle Ventures — 13 tracked in total.
- Status: Privately Held (backing).
Sonara's last reported valuation, Oct 2022. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Sonara: the Monday email on marks, rounds and moves
Sonara funding rounds
No funding rounds for Sonara are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Sonara
13+Sonara valuation
Sonara's last reported valuation was $13 million in Oct 2022. No priced round, secondary trade or fund mark has surfaced since.
Sonara investors
13 investors are on record for Sonara, including VentureWell, Mark Cuban, First Trust Capital Partners and Sorenson Impact Foundation.
About Sonara
Developer of a telehealth software designed to meet the specific needs of opioid addiction clinics and their patients. The company's software guides patients through their journey to recovery while providing their care team with the information needed to improve treatment plans, initiate timely interventions and expand access to care, enabling patients to overcome opioid addiction, thereby saving lives.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2020
- Employees
- 20
- Website
- sonarahealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.